Company profile for Tonghua Dongbao Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.Dongbao Group is located in the foothills of the Changbai Weiwei, known as " China Medical City " reputation of Tonghua City, Jilin Province, was founded in 1985 Nian 12 Yue 1 days.The life of an enterprise lies in exploration, and the life of a business lies in innovation. Independent innovation is the root and power source of ...
Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.Dongbao Group is located in the foothills of the Changbai Weiwei, known as " China Medical City " reputation of Tonghua City, Jilin Province, was founded in 1985 Nian 12 Yue 1 days.The life of an enterprise lies in exploration, and the life of a business lies in innovation. Independent innovation is the root and power source of Dongbao Group and Dongbao people's continuous development and leap forward. Under the leadership of President Li Yikui, Dongbao Group has the lofty ideal of " Science and technology serve the country

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Tonghua, Shanxi
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-10-15/adocia-and-tonghua-dongbao-announce-positive-topline-results-of-phase-3-clinical-trial-on-ultra-rapi

PHARMIWEB
15 Oct 2025

https://www.globenewswire.com/news-release/2021/10/14/2313915/0/en/Adocia-s-partner-Tonghua-Dongbao-Receives-Clearance-to-Start-Ultra-Rapid-Insulin-BioChaperone-Lispro-Phase-3-Trial-to-Treat-Type-1-and-Type-2-Diabetes-in-China.html

GLOBENEWSWIRE
14 Oct 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=108567&sid=2

PHARMABIZ
27 Apr 2018

ABOUT THIS PAGE

Contact Tonghua Dongbao Pharma and get a quotation

Tonghua Dongbao Pharma is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Insulin Glargine bulk with DMF offered by Tonghua Dongbao Pharma

Find a price of Liraglutide bulk offered by Tonghua Dongbao Pharma

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty